Medical Equipment News

Here at The Motley Fool, I've long cautioned investors to keep a close eye on inventory levels.

Pursuant to the Offering, the Company will issue 23,529,412 common shares at a price of .

Enterprise Ireland , a Dublin-based government agency that assists startups, is coming to Philadelphia this week for a trade mission focused on the region's life sciences industry.

A patient who fell through a kinetic therapy bed and as a result suffered gruesome bedsores and loss of his tailbone won a $1 million jury award against the bed's manufacturer.

EDAP TMS of Vaulx-en-Velin, France received CE Mark approval for its Focal - One robotic High-Intensity Focused Ultrasound system for non-invasive treatment of prostate cancer.

In Rumson, Things Are Looking Up: In Rumson, Things Are Looking Up. Theresa and Jim Azaceta of Rumson raise their Rumson home 8 feet after it flooded during Sandy.

Valeant Pharmaceuticals has set a bank meeting for Wednesday to launch a $9.3 billion financing package backing the company's $8.7 billion acquisition of Bausch & Lomb, sources told Thomson Reuters LPC.

"We are on schedule to release Phase 3 efficacy data for CRUISE-1 and look forward to those study results."

Law Offices of Howard G. Smith announces that it is investigating potential claims against Uroplasty, Inc. concerning possible violations of federal securities laws.

Hello Friends! Thanks so much for stopping by and visiting my blog, Stock Picks Bob's Advice ! As always, please remember that I am an amateur investor, so please remember to consult with your professional investment advisors prior to making any investment decisions based on information on this website.

Medtronic Inc.'s Infuse, designed to help bones heal after spinal surgery, works no better than a graft and carries side effects including an increased risk of cancer, two independent reviews found.

INTREPID is a prospective, multi-center, double-blinded, randomized, controlled study to evaluate the safety and effectiveness of motor function and overall quality of life in patients with the Vercise DBS System for the treatment of Parkinson's disease.

's stock had its "neutral" rating restated by equities researchers at Sterne Agee in a research report issued on Monday, StockRatingsNetwork.com reports.

St. Jude Medical won FDA approval for the new Ellipse and Assura lines of implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators .

Elevation Saved Mantoloking Home: Elevating his home when it was built 30 years ago, saved Ed Wright's Mantoloking home when the ocean met the bay the the foot of the Mantoloking Bridge during Superstorm Sandy.

Stock futures rose on Monday after major equity indexes on Friday closed their third negative week in four, with traders focused on this week's Federal Reserve policy meeting.

Woo Jeon VT, our Korean distributor, has successfully driven the ICL market share in the country to over 12% of all refractive procedures.

Summer days are coming and the financial market goes to hibernation. Last week was the weakest week in terms of dividend growth.

One factor: the world's largest eyewear company, the Italian firm Luxottica, controls a big chunk of the business.

Responding to heightened scrutiny of hospital billing and collection practices, the Healthcare Financial Management Association on Sunday released new guidelines aimed at improving provider communications with patients about paying for care.